Over 200 Total Lots Up For Auction at One Location - UT 06/15

UCI Health partners with Biofourmis for hospital at home and post-acute remote patient monitoring

Press releases may be edited for formatting or style | February 04, 2022 Business Affairs

“UCI Health is leading the industry in adopting more remote and virtual care models to safely care for their acute and post-acute care patients,” said Kuldeep Singh Rajput, founder and CEO of Biofourmis. “As this care virtualization initiative grows within the health system, the Biofourmis platform can be easily scaled and customized to enable UCI Health’s clinicians across numerous specialties to deliver exceptional care independent of a patient’s physical location.”

About Biofourmis
Biofourmis—a fast-growing global leader in digital therapeutics and virtual care that powers personalized predictive care—discovers, develops and delivers clinically validated software-based therapeutics to provide better outcomes for patients, advanced tools for clinicians to deliver personalized care, technology to demonstrate the value of and complement pharmacotherapy, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics product pipeline across multiple therapeutic areas—including heart failure, oncology, infectious disease (i.e., COVID-19), chronic pain, acute coronary syndrome and COPD. For more information, visit: www.biofourmis.com.

Back to HCB News

You Must Be Logged In To Post A Comment